In human PAH, ROCK inhibitors cause modest reductions in pulmonary vascular resistance.36 As such, ROCK has been implicated in both PA contraction and remodeling.37 Serotonin-induced PASMC proliferation, contraction, and migration involve ERK1/2 MAPK and ROCK. The gene discussed is MAPK3; the disease is pulmonary arterial hypertension.